Zhejiang Shouxiangu Pharm Co (603896) — Cash Flow Quality Index

Latest as of September 2025: 1.94x

Zhejiang Shouxiangu Pharm Co (603896) has a Cash Flow Quality Index of 1.94x as of September 2025. Operating cash flow of CN¥20.94 Million exceeds net income of CN¥10.78 Million, indicating high earnings quality where cash backs reported profits. Explore Zhejiang Shouxiangu Pharm Co cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.94x
Operating CF / Net Income

Operating Cash Flow

CN¥20.94 Million
CNY

Net Income

CN¥10.78 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhejiang Shouxiangu Pharm Co Cash Flow Quality Index (2012–2025)

Historical Cash Flow Quality Index for Zhejiang Shouxiangu Pharm Co across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Zhejiang Shouxiangu Pharm Co.

Annual Cash Flow Quality Index for Zhejiang Shouxiangu Pharm Co (2012–2025)

Year-by-year earnings quality comparison for Zhejiang Shouxiangu Pharm Co.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2025 12.55x CN¥228.07 Million CN¥18.17 Million ▲ +927.2%
2024 1.22x CN¥213.44 Million CN¥174.71 Million ▼ -1.3%
2023 1.24x CN¥315.06 Million CN¥254.48 Million ▲ +0.7%
2022 1.23x CN¥341.28 Million CN¥277.51 Million ▼ -17.0%
2021 1.48x CN¥296.70 Million CN¥200.31 Million ▼ -12.3%
2020 1.69x CN¥256.36 Million CN¥151.71 Million ▲ +0.7%
2019 1.68x CN¥207.92 Million CN¥123.90 Million ▲ +5.3%
2018 1.59x CN¥171.51 Million CN¥107.65 Million ▲ +27.8%
2017 1.25x CN¥110.80 Million CN¥88.88 Million ▲ +5.7%
2016 1.18x CN¥95.52 Million CN¥80.98 Million ▼ -13.1%
2015 1.36x CN¥85.03 Million CN¥62.64 Million ▼ -8.7%
2014 1.49x CN¥102.90 Million CN¥69.25 Million ▲ +22.0%
2013 1.22x CN¥65.85 Million CN¥54.05 Million ▼ -8.6%
2012 1.33x CN¥45.36 Million CN¥34.02 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.